4571.T
Nano Holdings,Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 101.00
+2.02%Year over year
Reported trailing growth
- Revenue
- +36.0%
- EBITDA
- —
- EBIT
- -31.7%
- EPS
- -38.1%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +0.6%
- EBITDA
- —
- EPS
- -17.6%
Three-year CAGR
- Revenue
- -25.8%
- EBITDA
- +12.5%
- EBIT
- +12.6%
- Net income
- -7.1%
- EPS
- -6.8%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026